APO Research

APO RESEARCH · REPORT

Sumatriptan Succinate

Selected research

Industry Growth & Trends

Global Sumatriptan Succinate Industry Growth and Trends Forecast to 2032

Market perspective

The global Sumatriptan Succinate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sumatriptan Succinate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sumatriptan Succinate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sumatriptan Succinate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sumatriptan Succinate include Teva, Merck, Mylan, Pfizer, Sun Pharmaceutical, GlaxoSmithKline and Endo Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sumatriptan Succinate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sumatriptan Succinate market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sumatriptan Succinate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sumatriptan Succinate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sumatriptan Succinate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sumatriptan Succinate Market by Company

Teva

Merck

Mylan

Pfizer

Sun Pharmaceutical

GlaxoSmithKline

Endo Pharmaceuticals

Sumatriptan Succinate Segment by Type

Tablet

Subcutaneous Injection

Nasal Spray

Sumatriptan Succinate Segment by Application

Hospital Pharmacies

Drug Stores

Sumatriptan Succinate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sumatriptan Succinate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sumatriptan Succinate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sumatriptan Succinate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sumatriptan Succinate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sumatriptan Succinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Subcutaneous Injection Table 3. Major Company of Nasal Spray Table 4. Global Sumatriptan Succinate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Sumatriptan Succinate Sales by Type (2021-2026) & (K Units) Table 6. Global Sumatriptan Succinate Sales Market Share in Volume by Type (2021-2026) Table 7. Global Sumatriptan Succinate Sales by Type (2021-2026) & (US$ Million) Table 8. Global Sumatriptan Succinate Sales Market Share in Value by Type (2021-2026) Table 9. Global Sumatriptan Succinate Price by Type (2021-2026) & (US$/Unit) Table 10. Global Sumatriptan Succinate Sales by Type (2027-2032) & (K Units) Table 11. Global Sumatriptan Succinate Sales Market Share in Volume by Type (2027-2032) Table 12. Global Sumatriptan Succinate Sales by Type (2027-2032) & (US$ Million) Table 13. Global Sumatriptan Succinate Sales Market Share in Value by Type (2027-2032) Table 14. Global Sumatriptan Succinate Price by Type (2027-2032) & (US$/Unit) Table 15. North America Sumatriptan Succinate Sales by Type (2021-2026) & (K Units) Table 16. North America Sumatriptan Succinate Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Sumatriptan Succinate Sales by Type (2021-2026) & (K Units) Table 18. Europe Sumatriptan Succinate Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Sumatriptan Succinate Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Sumatriptan Succinate Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Sumatriptan Succinate Sales by Type (2021-2026) & (K Units) Table 22. Latin America Sumatriptan Succinate Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Sumatriptan Succinate Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Sumatriptan Succinate Sales by Type (2021-2026) & (US$ Million) Table 25. Sumatriptan Succinate Industry Trends Table 26. Sumatriptan Succinate Industry Drivers Table 27. Sumatriptan Succinate Industry Opportunities and Challenges Table 28. Sumatriptan Succinate Industry Restraints Table 29. Global Sumatriptan Succinate Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Sumatriptan Succinate Revenue Market Share by Company (2021-2026) Table 31. Global Sumatriptan Succinate Sales by Company (2021-2026) & (K Units) Table 32. Global Sumatriptan Succinate Sales Share by Company (2021-2026) Table 33. Global Sumatriptan Succinate Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Sumatriptan Succinate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Sumatriptan Succinate Major Company Production Sites and Headquarters Table 36. Global Sumatriptan Succinate Company, Product Type & Application Table 37. Global Sumatriptan Succinate Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Sumatriptan Succinate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Sumatriptan Succinate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Sumatriptan Succinate Sales by Region (2021-2026) & (K Units) Table 42. Global Sumatriptan Succinate Sales Market Share in Volume by Region (2021-2026) Table 43. Global Sumatriptan Succinate Sales by Region (2021-2026) & (US$ Million) Table 44. Global Sumatriptan Succinate Sales Market Share in Value by Region (2021-2026) Table 45. Global Sumatriptan Succinate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Sumatriptan Succinate Sales by Region (2027-2032) & (K Units) Table 47. Global Sumatriptan Succinate Sales Market Share in Volume by Region (2027-2032) Table 48. Global Sumatriptan Succinate Sales by Region (2027-2032) & (US$ Million) Table 49. Global Sumatriptan Succinate Sales Market Share in Value by Region (2027-2032) Table 50. Global Sumatriptan Succinate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Sumatriptan Succinate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Sumatriptan Succinate Sales by Application (2021-2026) & (K Units) Table 53. Global Sumatriptan Succinate Sales Market Share in Volume by Application (2021-2026) Table 54. Global Sumatriptan Succinate Sales by Application (2021-2026) & (US$ Million) Table 55. Global Sumatriptan Succinate Sales Market Share in Value by Application (2021-2026) Table 56. Global Sumatriptan Succinate Price by Application (2021-2026) & (US$/Unit) Table 57. Global Sumatriptan Succinate Sales by Application (2027-2032) & (K Units) Table 58. Global Sumatriptan Succinate Sales Market Share in Volume by Application (2027-2032) Table 59. Global Sumatriptan Succinate Sales by Application (2027-2032) & (US$ Million) Table 60. Global Sumatriptan Succinate Sales Market Share in Value by Application (2027-2032) Table 61. Global Sumatriptan Succinate Price by Application (2027-2032) & (US$/Unit) Table 62. North America Sumatriptan Succinate Sales by Application (2021-2026) & (K Units) Table 63. North America Sumatriptan Succinate Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Sumatriptan Succinate Sales by Application (2021-2026) & (K Units) Table 65. Europe Sumatriptan Succinate Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Sumatriptan Succinate Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Sumatriptan Succinate Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Sumatriptan Succinate Sales by Application (2021-2026) & (K Units) Table 69. Latin America Sumatriptan Succinate Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Sumatriptan Succinate Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Sumatriptan Succinate Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Sumatriptan Succinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Sumatriptan Succinate Product Portfolio Table 76. Teva Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Sumatriptan Succinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck Sumatriptan Succinate Product Portfolio Table 81. Merck Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Sumatriptan Succinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Mylan Sumatriptan Succinate Product Portfolio Table 86. Mylan Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Sumatriptan Succinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Sumatriptan Succinate Product Portfolio Table 91. Pfizer Recent Development Table 92. Sun Pharmaceutical Company Information Table 93. Sun Pharmaceutical Business Overview Table 94. Sun Pharmaceutical Sumatriptan Succinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sun Pharmaceutical Sumatriptan Succinate Product Portfolio Table 96. Sun Pharmaceutical Recent Development Table 97. GlaxoSmithKline Company Information Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Sumatriptan Succinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline Sumatriptan Succinate Product Portfolio Table 101. GlaxoSmithKline Recent Development Table 102. Endo Pharmaceuticals Company Information Table 103. Endo Pharmaceuticals Business Overview Table 104. Endo Pharmaceuticals Sumatriptan Succinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Endo Pharmaceuticals Sumatriptan Succinate Product Portfolio Table 106. Endo Pharmaceuticals Recent Development Table 107. North America Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. North America Sumatriptan Succinate Sales by Country (2021-2026) & (K Units) Table 109. North America Sumatriptan Succinate Sales Market Share by Country (2021-2026) Table 110. North America Sumatriptan Succinate Sales Forecast by Country (2027-2032) & (K Units) Table 111. North America Sumatriptan Succinate Sales Market Share Forecast by Country (2027-2032) Table 112. North America Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Sumatriptan Succinate Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Sumatriptan Succinate Market Share by Country (2021-2026) Table 115. North America Sumatriptan Succinate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Sumatriptan Succinate Market Share Forecast by Country (2027-2032) Table 117. Europe Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Europe Sumatriptan Succinate Sales by Country (2021-2026) & (K Units) Table 119. Europe Sumatriptan Succinate Sales Market Share by Country (2021-2026) Table 120. Europe Sumatriptan Succinate Sales Forecast by Country (2027-2032) & (K Units) Table 121. Europe Sumatriptan Succinate Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Sumatriptan Succinate Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Sumatriptan Succinate Market Share by Country (2021-2026) Table 125. Europe Sumatriptan Succinate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Sumatriptan Succinate Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Sumatriptan Succinate Sales by Country (2021-2026) & (K Units) Table 129. Asia-Pacific Sumatriptan Succinate Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Sumatriptan Succinate Sales Forecast by Country (2027-2032) & (K Units) Table 131. Asia-Pacific Sumatriptan Succinate Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Sumatriptan Succinate Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Sumatriptan Succinate Market Share by Country (2021-2026) Table 135. Asia-Pacific Sumatriptan Succinate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Sumatriptan Succinate Market Share Forecast by Country (2027-2032) Table 137. Latin America Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Latin America Sumatriptan Succinate Sales by Country (2021-2026) & (K Units) Table 139. Latin America Sumatriptan Succinate Sales Market Share by Country (2021-2026) Table 140. Latin America Sumatriptan Succinate Sales Forecast by Country (2027-2032) & (K Units) Table 141. Latin America Sumatriptan Succinate Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Sumatriptan Succinate Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Sumatriptan Succinate Market Share by Country (2021-2026) Table 145. Latin America Sumatriptan Succinate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Sumatriptan Succinate Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Sumatriptan Succinate Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Sumatriptan Succinate Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Sumatriptan Succinate Sales Forecast by Country (2027-2032) & (K Units) Table 151. Middle East and Africa Sumatriptan Succinate Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Sumatriptan Succinate Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Sumatriptan Succinate Market Share by Country (2021-2026) Table 155. Middle East and Africa Sumatriptan Succinate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Sumatriptan Succinate Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Sumatriptan Succinate Distributors List Table 160. Sumatriptan Succinate Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Sumatriptan Succinate Image Figure 2. Global Sumatriptan Succinate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sumatriptan Succinate Market Size (2021-2032) & (US$ Million) Figure 4. Global Sumatriptan Succinate Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Subcutaneous Injection Image Figure 8. Global Subcutaneous Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Nasal Spray Image Figure 10. Global Nasal Spray Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Sumatriptan Succinate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Sumatriptan Succinate Market Share by Type 2025 VS 2032 Figure 13. North America Sumatriptan Succinate Sales Market Share in Volume by Type in 2025 Figure 14. North America Sumatriptan Succinate Sales Market Share in Value by Type in 2025 Figure 15. Europe Sumatriptan Succinate Sales Market Share in Volume by Type in 2025 Figure 16. Europe Sumatriptan Succinate Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Sumatriptan Succinate Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Sumatriptan Succinate Sales Market Share in Value by Type in 2025 Figure 19. Latin America Sumatriptan Succinate Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Sumatriptan Succinate Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Sumatriptan Succinate Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Sumatriptan Succinate Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Sumatriptan Succinate Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Drug Stores Image Figure 28. Global Drug Stores Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Sumatriptan Succinate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Sumatriptan Succinate Market Share by Application 2025 VS 2032 Figure 31. North America Sumatriptan Succinate Sales Market Share in Volume by Application in 2025 Figure 32. North America Sumatriptan Succinate Sales Market Share in Value by Application in 2025 Figure 33. Europe Sumatriptan Succinate Sales Market Share in Volume by Application in 2025 Figure 34. Europe Sumatriptan Succinate Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Sumatriptan Succinate Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Sumatriptan Succinate Sales Market Share in Value by Application in 2025 Figure 37. Latin America Sumatriptan Succinate Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Sumatriptan Succinate Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Sumatriptan Succinate Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Sumatriptan Succinate Sales Market Share in Value by Application in 2025 Figure 41. North America Sumatriptan Succinate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Sumatriptan Succinate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Sumatriptan Succinate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Sumatriptan Succinate Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sumatriptan Succinate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Sumatriptan Succinate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sumatriptan Succinate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Sumatriptan Succinate Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sumatriptan Succinate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Sumatriptan Succinate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sumatriptan Succinate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Sumatriptan Succinate Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sumatriptan Succinate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Sumatriptan Succinate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sumatriptan Succinate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Sumatriptan Succinate Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sumatriptan Succinate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Sumatriptan Succinate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sumatriptan Succinate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Sumatriptan Succinate Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Sumatriptan Succinate Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Sumatriptan Succinate Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Subcutaneous Injection
  • Nasal Spray
Applications
  • Hospital Pharmacies
  • Drug Stores
Companies covered
  • Teva
  • Merck
  • Mylan
  • Pfizer
  • Sun Pharmaceutical
  • GlaxoSmithKline
  • Endo Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sumatriptan Succinate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sumatriptan Succinate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sumatriptan Succinate Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Subcutaneous Injection
  8. 1.3.3 Nasal Spray
  9. 1.4 Global Sumatriptan Succinate Market Size by Type
  10. 1.4.1 Global Sumatriptan Succinate Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Sumatriptan Succinate Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Sumatriptan Succinate Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Sumatriptan Succinate Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Sumatriptan Succinate Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Sumatriptan Succinate Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Sumatriptan Succinate Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Sumatriptan Succinate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sumatriptan Succinate Industry Trends
  2. 2.2 Sumatriptan Succinate Industry Drivers
  3. 2.3 Sumatriptan Succinate Industry Opportunities and Challenges
  4. 2.4 Sumatriptan Succinate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sumatriptan Succinate Revenue (2021-2026)
  2. 3.2 Global Top Players by Sumatriptan Succinate Sales (2021-2026)
  3. 3.3 Global Top Players by Sumatriptan Succinate Price (2021-2026)
  4. 3.4 Global Sumatriptan Succinate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sumatriptan Succinate Major Company Production Sites & Headquarters
  6. 3.6 Global Sumatriptan Succinate Company, Product Type & Application
  7. 3.7 Global Sumatriptan Succinate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sumatriptan Succinate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sumatriptan Succinate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sumatriptan Succinate Tier 1, Tier 2, and Tier 3
4 Sumatriptan Succinate Regional Status and Outlook
  1. 4.1 Global Sumatriptan Succinate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sumatriptan Succinate Historic Market Size by Region
  3. 4.2.1 Global Sumatriptan Succinate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sumatriptan Succinate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sumatriptan Succinate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sumatriptan Succinate Forecasted Market Size by Region
  7. 4.3.1 Global Sumatriptan Succinate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sumatriptan Succinate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sumatriptan Succinate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sumatriptan Succinate by Application
  1. 5.1 Sumatriptan Succinate Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.2 Global Sumatriptan Succinate Market Size by Application
  5. 5.2.1 Global Sumatriptan Succinate Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Sumatriptan Succinate Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Sumatriptan Succinate Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Sumatriptan Succinate Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Sumatriptan Succinate Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Sumatriptan Succinate Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Sumatriptan Succinate Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Sumatriptan Succinate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Sumatriptan Succinate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Sumatriptan Succinate Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Sumatriptan Succinate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Sumatriptan Succinate Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Sumatriptan Succinate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Sumatriptan Succinate Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Sumatriptan Succinate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Sumatriptan Succinate Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Sun Pharmaceutical
  26. 6.5.1 Sun Pharmaceutical Company Information
  27. 6.5.2 Sun Pharmaceutical Business Overview
  28. 6.5.3 Sun Pharmaceutical Sumatriptan Succinate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sun Pharmaceutical Sumatriptan Succinate Product Portfolio
  30. 6.5.5 Sun Pharmaceutical Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Sumatriptan Succinate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Sumatriptan Succinate Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Endo Pharmaceuticals
  38. 6.7.1 Endo Pharmaceuticals Company Information
  39. 6.7.2 Endo Pharmaceuticals Business Overview
  40. 6.7.3 Endo Pharmaceuticals Sumatriptan Succinate Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Endo Pharmaceuticals Sumatriptan Succinate Product Portfolio
  42. 6.7.5 Endo Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Sumatriptan Succinate Sales by Country
  2. 7.1.1 North America Sumatriptan Succinate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sumatriptan Succinate Sales by Country (2021-2026)
  4. 7.1.3 North America Sumatriptan Succinate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sumatriptan Succinate Market Size by Country
  6. 7.2.1 North America Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sumatriptan Succinate Market Size by Country (2021-2026)
  8. 7.2.3 North America Sumatriptan Succinate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sumatriptan Succinate Sales by Country
  2. 8.1.1 Europe Sumatriptan Succinate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sumatriptan Succinate Sales by Country (2021-2026)
  4. 8.1.3 Europe Sumatriptan Succinate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sumatriptan Succinate Market Size by Country
  6. 8.2.1 Europe Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sumatriptan Succinate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sumatriptan Succinate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sumatriptan Succinate Sales by Country
  2. 9.1.1 Asia-Pacific Sumatriptan Succinate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sumatriptan Succinate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sumatriptan Succinate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sumatriptan Succinate Market Size by Country
  6. 9.2.1 Asia-Pacific Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sumatriptan Succinate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sumatriptan Succinate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sumatriptan Succinate Sales by Country
  2. 10.1.1 South America Sumatriptan Succinate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sumatriptan Succinate Sales by Country (2021-2026)
  4. 10.1.3 South America Sumatriptan Succinate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sumatriptan Succinate Market Size by Country
  6. 10.2.1 South America Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sumatriptan Succinate Market Size by Country (2021-2026)
  8. 10.2.3 South America Sumatriptan Succinate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sumatriptan Succinate Sales by Country
  2. 11.1.1 Middle East and Africa Sumatriptan Succinate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sumatriptan Succinate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sumatriptan Succinate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sumatriptan Succinate Market Size by Country
  6. 11.2.1 Middle East and Africa Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sumatriptan Succinate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sumatriptan Succinate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sumatriptan Succinate Value Chain Analysis
  2. 12.1.1 Sumatriptan Succinate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sumatriptan Succinate Production Mode & Process
  7. 12.2 Sumatriptan Succinate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sumatriptan Succinate Distributors
  10. 12.2.3 Sumatriptan Succinate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research